Samalin Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-472
Closed -$224K 343
2026
Q1
$224K Sell
472
-117
-20% -$58.9K 0.08% 270
2025
Q4
$275K Sell
589
-44
-7% -$20.4K 0.1% 249
2025
Q3
$270K Buy
633
+1
+0.2% +$388 0.09% 268
2025
Q2
$242K Buy
632
+1
+0.2% +$360 0.09% 275
2025
Q1
$218K Buy
+631
New +$203K 0.09% 283
2024
Q4
Sell
-523
Closed -$212K 311
2024
Q3
$212K Buy
+523
New +$191K 0.09% 254

Other funds holding HCA

Samalin Investment Counsel's HCA Position: Q2 2026 in Review

Samalin Investment Counsel sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 472 shares — an estimated $224K sold.

Samalin Investment Counsel first reported a position in HCA in Q3 2024 and held it in 6 quarters. The position peaked at $275K in Q4 2025. 586 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Samalin Investment Counsel reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Samalin Investment Counsel sold 472 HCA Healthcare shares in Q2 2026, an estimated $224K.
  • Samalin Investment Counsel first reported a position in HCA Healthcare in Q3 2024 and held it in 6 quarters.
  • Samalin Investment Counsel's HCA Healthcare position peaked at $275K in Q4 2025.
  • 586 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.